Evercore ISI Lowers Healthpeak Properties (NYSE:DOC) Price Target to $21.00

Healthpeak Properties (NYSE:DOC) had its price objective decreased by Evercore ISI from $22.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Evercore ISI’s price objective would indicate a potential upside of 25.11% from the stock’s previous close.

DOC has been the subject of several other reports. Cantor Fitzgerald initiated coverage on Healthpeak Properties in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price for the company. Wells Fargo & Company upped their price objective on shares of Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 12th. Finally, Morgan Stanley reduced their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday, August 22nd. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $20.50.

Healthpeak Properties Trading Up 1.0%

Shares of Healthpeak Properties stock traded up $0.17 on Monday, reaching $16.79. The company had a trading volume of 229,026 shares, compared to its average volume of 6,615,239. Healthpeak Properties has a 52-week low of $16.44 and a 52-week high of $21.28. The firm’s 50 day moving average price is $17.89 and its two-hundred day moving average price is $17.85. The firm has a market cap of $11.66 billion, a PE ratio of -335.23, a PEG ratio of 4.21 and a beta of 1.11. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.22 and a current ratio of 1.22.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter last year, the company posted $0.45 EPS. The firm’s revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Healthpeak Properties

A number of large investors have recently added to or reduced their stakes in DOC. Baird Financial Group Inc. grew its holdings in Healthpeak Properties by 38.5% during the 2nd quarter. Baird Financial Group Inc. now owns 402,466 shares of the real estate investment trust’s stock worth $7,047,000 after acquiring an additional 111,807 shares during the period. Wealthedge Investment Advisors LLC raised its holdings in Healthpeak Properties by 417.5% during the second quarter. Wealthedge Investment Advisors LLC now owns 163,959 shares of the real estate investment trust’s stock worth $2,871,000 after buying an additional 132,274 shares during the last quarter. Adelante Capital Management LLC raised its stake in shares of Healthpeak Properties by 4,464.2% in the first quarter. Adelante Capital Management LLC now owns 1,189,069 shares of the real estate investment trust’s stock worth $24,043,000 after purchasing an additional 1,163,017 shares during the last quarter. Aviva PLC lifted its stake in Healthpeak Properties by 6.6% during the 2nd quarter. Aviva PLC now owns 593,721 shares of the real estate investment trust’s stock valued at $10,396,000 after acquiring an additional 36,603 shares in the last quarter. Finally, Alan B Lancz & Associates Inc. purchased a new position in Healthpeak Properties during the second quarter worth about $373,000. 93.57% of the stock is owned by institutional investors and hedge funds.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.